1015 Chestnut Street
Suite 1020
Philadelphia, PA 19107
(215) 955-7785
(215) 955-9362 fax
Suite 1020
Philadelphia, PA 19107
(215) 955-7785
(215) 955-9362 fax
Most Recent Peer-reviewed Publications
- Rilpivirine, a novel non-nucleoside reverse transcriptase inhibitor for the management of HIV-1 infection: A systematic review
- Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE
- Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials
- Prevalence of obstructive lung disease in HIV population: A cross sectional study
- Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus
- Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor
- Fatal herpes simplex virus type 2 pneumonia in a person with AIDS